Data protection Impressum

R&D

An interdisciplinary team from the University of Bern and Inselspital has developed CARESCORE, an AI model that calculates a patient's individual risk of postoperative infection within seconds of surgery ending, by drawing on vital signs recorded during the procedure.

Bern researchers develop an AI model that predicts infection risk at the end of surgery

31 August 2026

Building on its pilot plant in the Neuchâtel mountains, Sun-Ways has signed an agreement with its first commercial partner in Italy, entered a technology agreement with France's SNCF and received government approval for a first project in South Korea.

Sun-Ways takes its rail-mounted solar technology to Italy, France and South Korea

31 August 2026

The canton of Fribourg has officially handed over to the Confederation the keys to Agroscope's new laboratory building in Posieux, a CHF 125 million facility that forms the centerpiece of the national agricultural research center's site strategy.

Agroscope opens its new CHF 125 million laboratory in Fribourg

20 August 2026

Spineart, the Geneva-based medtech company specializing in spine surgery, has received FDA approval for its BAGUERA C cervical disc for one and two contiguous levels, expanding access in the United States to a motion-preserving solution for cervical disc disease.

Spineart receives FDA approval for its BAGUERA C cervical disc

20 August 2026

A new study conducted at Bern’s University Hospital shows that VisionOne, the virtual reality eye-testing platform developed by Vaud-based PeriVision, delivers clinical performance comparable to the stationary perimeter considered the gold standard, including in advanced glaucoma.

PeriVision’s VR eye test matches the gold standard across glaucoma severity

17 August 2026

Oculis, the Lausanne-based biopharmaceutical company focused on ophthalmology and neuro-ophthalmology, will acquire all worldwide development and commercial rights to Privosegtor from Accure, terminating its existing license agreement.

Oculis acquires worldwide rights to its Privosegtor candidate

17 August 2026

Researchers at EPFL, with colleagues from the University of Geneva, Geneva University Hospitals and Zurich, have developed VirTues, an AI foundation model for tissue biology that analyzes tumor tissue across many cancer types, with results published in Nature.

EPFL’s VirTues AI model maps tumor tissue across cancer types

17 August 2026

LS Instruments, a Fribourg-based maker of advanced light scattering and microrheology instruments, has been acquired by Germany's Postnova Analytics, with operations, manufacturing and the existing team remaining at its Fribourg headquarters.

LS Instruments joins Postnova Analytics while keeping its operations in Fribourg

12 August 2026

AB2 Bio has received a USD 30 million payment after Japanese pharmaceutical company Nippon Shinyaku exercised its option to commercialize Tadekinig alfa in the United States, with up to USD 600 million in further milestone and royalty payments.

AB2 Bio receives USD 30 million as Nippon Shinyaku takes up US rights

3 August 2026

Actival, a CSEM spin-off based in Neuchâtel, has been awarded a CHF 1.4 million grant from Innosuisse to accelerate the development and market launch of its patented Active Splints, a new generation of dental aligners that dispense antibacterial fluid and fluoride.

Actival secures a CHF 1.4 million Innosuisse grant for its smart dental aligners

3 August 2026

1 2 3 4 5 … 17